Research set to be presented in Los Angeles links hearing loss to type 2 diabetes, cognitive decline, and the growing GLP-1 medication landscape—underscoring hearing health's expanding role in whole-body care.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.